Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term, Open-Label, Multicenter, Extension Study of Bosentan in Patients With Pulmonary Hypertension Associated With Sickle Cell Disease Completing a Double-Blind ASSET Study (AC-052-368 or AC 052-369)

NCT00360087 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT00360087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00360087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term, Open-Label, Multicenter, Extension Study of Bosentan in Patients With Pulmonary Hypertension Associated With Sickle Cell Disease Completing a Double-Blind ASSET Study (AC-052-368 or AC 052-369)
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2006
Completion date
December 31, 2007
Enrollment
236
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, sickle cell anemia